Anamnesis
Lǐ*, age 48, type 2 diabetes for 7 years. Right metatarsophalangeal joint ulcer for 20 days, fever for 7 days. History: arterial hypertension, coronary heart disease, type 2 diabetes.
Treatment plan
Stem-cell gel applied topically to the wound surface.
- Therapy
- Stem cell gel (topical)
- Delivery route
- Topical
Outcome
After three gel applications, the wound surface had essentially healed. Granulation tissue was prominent — pink in color, with no signs of infection and normal discharge.
Background
Diabetic foot is a condition in which diabetic patients suffer reduced protective function in the lower limbs due to neurovascular impairment. Macro- and microvascular disease leads to arterial hypoperfusion and microcirculatory dysfunction, resulting in ulceration and gangrene. Diabetic foot is a serious complication of diabetes and a leading cause of disability and mortality; in addition to physical suffering, it imposes a significant economic burden.
Clinical photos
- Before cell therapy (2022-05-27): right foot metatarsophalangeal joint ulcer pre-treatment
- After cell therapy (2022-06-07): healed after 3 gel applications
Physician conclusion
No adverse reactions observed. Stem-cell gel treatment for diabetic foot is currently in Phase II clinical trials and demonstrates good clinical efficacy — a simple, safe, and effective treatment modality.
Discuss your case
Share your diagnosis and history — the academic board responds within 24 hours with a preliminary assessment and protocol outline.
Get a consultation